The Neurology study of 32,802 U.S. Health and Retirement Study participants over 25 years found quitting smoking lowered dementia incidence to levels comparable to never-smokers, with benefits plateauing around seven years post-cessation and slower cognitive decline (0.19 points per decade). However, gains were confined to those with ≤5 kg weight gain; >10 kg erased statistical significance. This prospective cohort design, while large, remains observational and susceptible to residual confounding from unmeasured lifestyle shifts or healthier baseline traits among successful quitters, unlike RCTs that could isolate effects. Related research, such as the 2019 Lancet Commission on dementia prevention, reinforces smoking as a modifiable risk factor but stresses multi-domain interventions; a 2023 meta-analysis in JAMA Network Open similarly noted post-cessation weight trajectories as understudied modifiers. The original coverage underplays these design constraints and the absence of conflict-of-interest disclosures, missing how modest weight management could amplify public-health impact for the millions attempting cessation annually.